| Danna M Perez Torruella, MD | |
|
Hc 6 Box 8589, Juana Diaz, PR 00795-9610 | |
| (787) 619-4718 | |
| Not Available |
| Full Name | Danna M Perez Torruella |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | Hc 6 Box 8589, Juana Diaz, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255729554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 18981 (Puerto Rico) | Primary |
| Entity Name | Primary Medical Group Csp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174593545 PECOS PAC ID: 4385556083 Enrollment ID: O20040626000264 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
Investing in affordable housing that offers supportive social services to senior citizens on Medicare has the potential to reduce hospital admissions and the amount of time needing inpatient hospital care by better managing chronic health conditions, according to a Rutgers study.
› Verified 6 days ago
| Entity Name | Primary Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417927898 PECOS PAC ID: 5890001630 Enrollment ID: O20150825003720 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
Investing in affordable housing that offers supportive social services to senior citizens on Medicare has the potential to reduce hospital admissions and the amount of time needing inpatient hospital care by better managing chronic health conditions, according to a Rutgers study.
› Verified 6 days ago
| Entity Name | Metro Pavia Healthcare Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760723696 PECOS PAC ID: 8022232271 Enrollment ID: O20160630000203 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
Investing in affordable housing that offers supportive social services to senior citizens on Medicare has the potential to reduce hospital admissions and the amount of time needing inpatient hospital care by better managing chronic health conditions, according to a Rutgers study.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danna M Perez Torruella, MD Hc 6 Box 8589, Juana Diaz, PR 00795-9610 Ph: (787) 486-3009 | Danna M Perez Torruella, MD Hc 6 Box 8589, Juana Diaz, PR 00795-9610 Ph: (787) 619-4718 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
Investing in affordable housing that offers supportive social services to senior citizens on Medicare has the potential to reduce hospital admissions and the amount of time needing inpatient hospital care by better managing chronic health conditions, according to a Rutgers study.
› Verified 6 days ago
Jose J Perez Ramos, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 79 Calle Munoz Rivera, Juana Diaz, PR 00795 Phone: 787-673-5212 | |
Dr. Adriana Ivelisse Torres-rodriguez, MD General Practice Medicare: Medicare Enrolled Practice Location: 48 Calle Siena, Juana Diaz, PR 00795 Phone: 787-601-2827 | |
Dr. Brenda I. Lopez, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: La Fe Plaza A-3 Bo. Sabana Llana, Juana Diaz, PR 00795 Phone: 787-260-1980 Fax: 787-260-1980 | |
Dr. Jancy Ninnette Acosta, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Urb. Tomas Carrion Maduro, Calle 6 #11, Juana Diaz, PR 00795 Phone: 787-367-5050 | |
Moraima Pagan La Torre, M.D. General Practice Medicare: Medicare Enrolled Practice Location: #5 Calle Santiago Iglesias, Juana Diaz, PR 00795 Phone: 787-260-0087 Fax: 787-260-0087 | |
Dr. Raymond Martinez Aponte, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Ave. Luis Munoz Rivera #29, Suite 2, Juana Diaz, PR 00795 Phone: 787-837-1051 Fax: 787-837-1051 | |
Dr. Marcial Castillo, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Hc 02 Box 8992, Juana Diaz, PR 00795 Phone: 787-315-3799 Fax: 787-845-1193 |